MONHEIM, Germany—Radianskin from Laboratoires Sérobiologiques (LS), Cognis’ active ingredient business, is a new skin lightener. Its active ingredient is a pure single molecule and provides a significant and visible lightening effect. Based on a scientific approach, Radianskin employs an alternate mode of action when compared to commonly used tyrosinase inhibitors and offers a good photo-protective effect helping to prevent skin against UV-induced damages while ensuring high skin tolerance due to its positive safety profile.
In unpublished clinical studies performed on Asian volunteers have shown 1 percent Radianskin significantly lightens the skin after as little as 28 days of treatment, with a lightening effect comparable to market benchmarks. Other in vitro efficacy studies have also proven the active’s photo-protective effect against UVB-induced damage, its good skin penetration, and its inhibition of melanogenesis compared to well-known skin lightening products, without any cytotoxic effects.
Radianskin is compatible with a wide range of other ingredients such as aluminum salts, AHAs, vitamin C, sun filters and TiO2. It offers excellent stability does not affect the color or odor of final formulations. It can be formulated in whitening ranges, lightening care products, anti-aging skin care products to improve skin radiance, anti-age spot creams and serums, men’s care products and whitening body care (hands, armpits, chest and forearms).